References
- Bray F, Ferlay, Ferlay J, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424. .
- Cabanillas ME, Mcfadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783.
- Warakomski J, Romuk E, Jarząb B, et al. Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages. Int J Endocrinol. 2018;2018:1–7.
- Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an Iron-Dependent Form of Nonapoptotic Cell Death. CELL. 2012;149(5):1060–1072.
- Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379. .
- Liang C, Zhang X, Yang M, et al. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019;31(51):51.
- Hassannia B, Vandenabeele P, Berghe TV. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35(6):830–849.
- Sato M, Kusumi R, Hamashima S, et al. The ferroptosis inducer erastin irreversibly inhibits system xc and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep. 2018;8(1):968. .
- Kinowaki Y, Kurata M, Ishibashi S, et al. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab Invest. 2018;98(5):609–619. .
- Jiang L, Ning K, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015,520(7545):57–62.
- Liang JY, Wang DS, Lin HC, et al. Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Int J Biol Sci. 2020;16(13):2430–2441.
- Shi ZZ, Fan ZW, Chen YX, et al. Ferroptosis in Carcinoma: regulatory Mechanisms and New Method for Cancer Therapy. Onco Targets Ther. 2019;12:11291–11304.
- Stockwell BR, Angeli JPF, Bayir H. Ferroptosis: a Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273–285.
- Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:7784.
- Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:7784.
- Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. .
- Simon N, Friedman JH, Hastie T, et al. Regularization Paths for Cox’s Proportional Hazards Model via Coordinate Descent. J Stat Softw. 2011;39(5):1–13.
- Saadatpour A, Lai S, Guo G, et al. Single-Cell Analysis in Cancer Genomics. Trends Genet. 2015;31(10):576–586.
- Terry M. Therneau PMG. Modeling Survival Data: extending the Cox Model. New York: Springer; 2000.
- Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381–5397.
- Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
- Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.
- Elgendy SM, Alyammahi SK, Alhamad DW, et al. Ferroptosis: an emerging approach for targeting cancer stem cells and drug resistance. Crit Rev Oncol Hematol. 2020;155:103095.
- Florean C, Song S, Dicato M, et al. Redox biology of regulated cell death in cancer: a focus on necroptosis and ferroptosis. In Free Radic Biol Med. 2019.134:177–189.
- Xie Y, Zhu S, Song X, et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Rep. 2017;20(7):1692. .
- Kerins MJ, Ooi A. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxid Redox Signal. 2017;29:17.
- Shimada K, Skouta, Skouta R, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497–503. .
- Kwon MY, Park E, Lee SJ, et al. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6(27):24393–24403.
- Gao M, Yi J, Zhu J, et al. Role of Mitochondria in Ferroptosis.Mol Cell.2019.73(2):354-363.e3.
- Gao M, Monian P, Quadri N, et al. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015;59(2):298–308.
- Ozóg J, Jarzab M, Pawlaczek A, et al. Expression of DPP4 gene in papillary thyroid carcinoma. Endokrynol Pol. 2006. 57 Suppl A: 12–7.
- Sloot YJE, Rabold K, Ulas T, et al. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration. Cell Oncol (Dordr). 2019;42(Suppl):1.
- Gulubova MV, Ivanova KV. The Expression of Tumor-Associated Macrophages and Multinucleated Giant Cells in Papillary Thyroid Carcinoma. Open Access Maced J Med Sci. 2019;7:23.
- Zhang L, Chen J, Xu C, et al. Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells of patients with differentiated thyroid carcinoma. Exp Ther Med. 2018;15(3):2661.